Literature DB >> 19536874

Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.

William F Anderson1, Ruth M Pfeiffer, Margaret A Tucker, Philip S Rosenberg.   

Abstract

BACKGROUND: Emerging data suggest that cutaneous malignant melanomas (CMM) may arise through divergent cancer pathways that are linked to intermittent versus accumulated sun exposure. However, numerous questions remain regarding the timing and/or age of exposure.
METHODS: The authors systematically examined the effect of aging on CMM incidence in data from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Standard descriptive epidemiology was supplemented with mathematical models. The impact of advancing age on CMM incidence was assessed by sex, histopathologic classification (superficial spreading melanoma [SSM] or lentigo maligna melanoma [LMM]), and anatomic site (face, head, and neck [FHN] or lower extremity [LE]).
RESULTS: Sex, histopathology, and anatomic site were age-specific effect modifiers for CMM that indicated divergent (bimodal) early-onset and late-onset cancer pathways. Early-onset melanomas were associated predominantly with women, SSM, and LE. Late-onset melanomas were correlated with men, LMM, and FHN. Early- and late-onset melanoma populations were confirmed with age-period-cohort models that were adjusted for period and cohort effects. Two-component mixture models also fit the data better than a single cancer population.
CONCLUSIONS: The current results were consistent with a divergent and age-dependent solar hypothesis for CMM. Early-onset melanomas may represent gene-sun exposure interactions that occur early (and/or intermittently) in life among susceptible individuals. Late-onset melanomas may reflect accumulated, lifelong sun exposure in comparatively less susceptible individuals. Future analytical studies should be powered adequately to account for this age-dependent effect modification both for acknowledged melanoma risk factors (sex, histopathology, and anatomic site) and for suspected melanoma risk factors, such as constituent genetic variants.

Entities:  

Mesh:

Year:  2009        PMID: 19536874      PMCID: PMC2741537          DOI: 10.1002/cncr.24481

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.

Authors:  William F Anderson; Nilanjan Chatterjee; William B Ershler; Otis W Brawley
Journal:  Breast Cancer Res Treat       Date:  2002-11       Impact factor: 4.872

2.  The classification of melanoma and its relationship with prognosis.

Authors:  V J McGovern
Journal:  Pathology       Date:  1970-04       Impact factor: 5.306

3.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Authors:  W H Clark; L From; E A Bernardino; M C Mihm
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

4.  Melanocytic and nevocytic malignant melanomas. Cellular and subcellular differentiation.

Authors:  Y Mishima
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

Review 5.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Authors:  C M Balch; A C Buzaid; S J Soong; M B Atkins; N Cascinelli; D G Coit; I D Fleming; J E Gershenwald; A Houghton; J M Kirkwood; K M McMasters; M F Mihm; D L Morton; D S Reintgen; M I Ross; A Sober; J A Thompson; J F Thompson
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

6.  Occupational sunlight exposure and cancer incidence among Swedish construction workers.

Authors:  N Håkansson; B Floderus; P Gustavsson; M Feychting; N Hallin
Journal:  Epidemiology       Date:  2001-09       Impact factor: 4.822

7.  Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand.

Authors:  J L Bulliard
Journal:  Int J Cancer       Date:  2000-03-01       Impact factor: 7.396

8.  Determinants of BRAF mutations in primary melanomas.

Authors:  Janet L Maldonado; Jane Fridlyand; Hetal Patel; Ajay N Jain; Klaus Busam; Toshiro Kageshita; Tomomichi Ono; Donna G Albertson; Dan Pinkel; Boris C Bastian
Journal:  J Natl Cancer Inst       Date:  2003-12-17       Impact factor: 13.506

9.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.

Authors:  David C Whiteman; Peter Watt; David M Purdie; Maria Celia Hughes; Nicholas K Hayward; Adèle C Green
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

10.  Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.

Authors:  Yoram Cohen; Eli Rosenbaum; Shahnaz Begum; David Goldenberg; Clemens Esche; Ofer Lavie; David Sidransky; William H Westra
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531

View more
  23 in total

1.  Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

Authors:  Erin X Wei; Abrar A Qureshi; Jiali Han; Tricia Y Li; Eunyoung Cho; Jennifer Y Lin; Wen-Qing Li
Journal:  J Am Acad Dermatol       Date:  2016-07-16       Impact factor: 11.527

2.  Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.

Authors:  Kathrine Rugbjerg; Søren Friis; Christina Funch Lassen; Beate Ritz; Jørgen H Olsen
Journal:  Int J Cancer       Date:  2012-03-22       Impact factor: 7.396

3.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

4.  Qualitative age interactions in breast cancer studies: mind the gap.

Authors:  William F Anderson; Ismail Jatoi; Mark E Sherman
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

5.  A web tool for age-period-cohort analysis of cancer incidence and mortality rates.

Authors:  Philip S Rosenberg; David P Check; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-08-21       Impact factor: 4.254

6.  Age-period-cohort models in cancer surveillance research: ready for prime time?

Authors:  Philip S Rosenberg; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

7.  Cancer incidence among priests: 45 years of follow-up in four Nordic countries.

Authors:  Andreas Stang; Jan Ivar Martinsen; Kristina Kjaerheim; Elisabete Weiderpass; Pär Sparén; Laufey Tryggvadóttir; Eero Pukkala
Journal:  Eur J Epidemiol       Date:  2011-12-27       Impact factor: 8.082

8.  Melanoma Tumor Characteristics: An Analysis of Mutational Burden and Copy Number Alterations by Patient Age and Stage.

Authors:  Ruzica Z Conic; Joshua Arbesman
Journal:  J Invest Dermatol       Date:  2017-12-05       Impact factor: 8.551

9.  Impact of age on the management of primary melanoma patients.

Authors:  Nathaniel H Fleming; Jiaying Tian; Eleazar Vega-Saenz de Miera; Heidi Gold; Farbod Darvishian; Anna C Pavlick; Russell S Berman; Richard L Shapiro; David Polsky; Iman Osman
Journal:  Oncology       Date:  2013-08-30       Impact factor: 2.935

10.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.